Abstract
There are currently no nanoparticle formulations that optimally target diseased cells in the body. A small percentage of nanoparticles reach these cells and most accumulate in cells of the mononuclear phagocytic system. This chapter explores the interactions between nanoparticles and cells that may explain the causes for off-target accumulation of nanoparticles. A greater understanding of the nanoparticle-cellular interactions will lead to improvements in particle design for improved therapeutic outcome.
Original language | English |
---|---|
Pages (from-to) | 227-244 |
Number of pages | 18 |
Journal | Cancer Treatment and Research |
Volume | 166 |
DOIs | |
Publication status | Published - 2015 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© Springer International Publishing Switzerland 2015.
ASJC Scopus Subject Areas
- Oncology
- Cancer Research
Keywords
- Cancer targeting
- Nano-biointeractions
- Nanomedicine
- Nanoparticle cell interaction